CoChat

Extracellular Vesicles Derived from Gut Microbiota, Especially Akkermansia muciniphila, Protect the Progression of Dextran Sulfate Sodium-Induced Colitis

Open access

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

Gut microbiota play an important part in the pathogenesis of mucosal inflammation, such as inflammatory bowel disease (IBD). However, owing to the complexity of the gut microbiota, our understanding of the roles of commensal and pathogenic bacteria in the maintenance of immune homeostasis in the gut is evolving only slowly. Here, we evaluated the role of gut microbiota and their secreting extracellular vesicles (EV) in the development of mucosal inflammation in the gut. Experimental IBD model was established by oral application of dextran sulfate sodium (DSS) to C57BL/6 mice. The composition of gut microbiota and bacteria-derived EV in stools was evaluated by metagenome sequencing using bacterial common primer of 16S rDNA. Metagenomics in the IBD mouse model showed that the change in stool EV composition was more drastic, compared to the change of bacterial composition. Oral DSS application decreased the composition of EV from Akkermansia muciniphila and Bacteroides acidifaciens in stools, whereas increased EV from TM7 phylum, especially from species DQ777900_s and AJ400239_s. In vitro pretreatment of A. muciniphila-derived EV ameliorated the production of a pro-inflammatory cytokine IL-6 from colon epithelial cells induced by Escherichia coli EV. Additionally, oral application of A. muciniphila EV also protected DSS-induced IBD phenotypes, such as body weight loss, colon length, and inflammatory cell infiltration of colon wall. Our data provides insight into the role of gut microbiota-derived EV in regulation of intestinal immunity and homeostasis, and A. muciniphila-derived EV have protective effects in the development of DSS-induced colitis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0076520

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Characterization of stool EV from a DSS-induced colitis mouse model. For all figures, C57BL/6 mice (each group = 5) were ingested by water or 3% DSS. (A) Body weight changes (%, left panel), colon length (middle panel), and disease activity index including body weight, colon length, diarrhea, and stool blood (right panel). Water: water-administered group; DSS: 3% DSS-administered group; *, p<0.05; ***, p<0.001. (B) TEM images (×80 k) of EV isolated from stools on days 0 and 5. D0; stools before DSS application; D5: stools 5 days after 3% DSS application. (C) EV sizes (d.nm) measured by nanoparticle tracking analysis (NTA) on day 0 through day 5. (D) EV extraction amounts (protein concentration per gram stool) from stools D0 – D5. (E) Protein profiles in EV (D0 – D5) through SDS-PAGE by using coomassie brilliant blue G250 dye.
Figure 1 Characterization of stool EV from a DSS-induced colitis mouse model. For all figures, C57BL/6 mice (each group = 5) were ingested by water or 3% DSS. (A) Body weight changes (%, left panel), colon length (middle panel), and disease activity index including body weight, colon length, diarrhea, and stool blood (right panel). Water: water-administered group; DSS: 3% DSS-administered group; *, p<0.05; ***, p<0.001. (B) TEM images (×80 k) of EV isolated from stools on days 0 and 5. D0; stools before DSS application; D5: stools 5 days after 3% DSS application. (C) EV sizes (d.nm) measured by nanoparticle tracking analysis (NTA) on day 0 through day 5. (D) EV extraction amounts (protein concentration per gram stool) from stools D0 – D5. (E) Protein profiles in EV (D0 – D5) through SDS-PAGE by using coomassie brilliant blue G250 dye.CC BY · PubMed Central
Figure 2 The composition of bacterial and bacteria-derived EV in stools following 3% DSS administration. For all figures, stool bacteria and EV were isolated from mice before (D0) and 5 days (D5) after 3% DSS oral administration (each group = 5). As for EV metagenomics, two independent experiments were performed. (A) Operational taxonomic units (OTUs) using Roche 454 GS FLX Titanium. For figures (B)–(D), the proportion of stool bacteria and bacterial EV is displayed at the phylum (B), genus (C), and species (D) levels. As for genus and species, the proportion less than 1% occupancy is noted as others.
Figure 2 The composition of bacterial and bacteria-derived EV in stools following 3% DSS administration. For all figures, stool bacteria and EV were isolated from mice before (D0) and 5 days (D5) after 3% DSS oral administration (each group = 5). As for EV metagenomics, two independent experiments were performed. (A) Operational taxonomic units (OTUs) using Roche 454 GS FLX Titanium. For figures (B)–(D), the proportion of stool bacteria and bacterial EV is displayed at the phylum (B), genus (C), and species (D) levels. As for genus and species, the proportion less than 1% occupancy is noted as others.CC BY · PubMed Central
Figure 3 The composition of bacteria and bacteria-derived EV in small intestinal fluids following 3% DSS administration. For all figures, bacteria and EV were isolated from small intestinal fluids of mice before (D0) and 5 days (D5) after 3% DSS oral administration (each group = 5). (A) EV TEM images (×100 k, left panel) and protein profiles through SDS-PAGE by using coomassie brilliant blue G250 dye (right panel). (B) Operational taxonomic units (OTUs) of bacteria and bacterial EV using Roche 454 GS FLX Titanium. For figures (C)–(E), the proportion of bacteria and bacterial EV in small intestinal fluids is displayed at the phylum (C), genus (D), and species (E) levels. As for genus and species, the proportion less than 1% occupancy is noted as others.
Figure 3 The composition of bacteria and bacteria-derived EV in small intestinal fluids following 3% DSS administration. For all figures, bacteria and EV were isolated from small intestinal fluids of mice before (D0) and 5 days (D5) after 3% DSS oral administration (each group = 5). (A) EV TEM images (×100 k, left panel) and protein profiles through SDS-PAGE by using coomassie brilliant blue G250 dye (right panel). (B) Operational taxonomic units (OTUs) of bacteria and bacterial EV using Roche 454 GS FLX Titanium. For figures (C)–(E), the proportion of bacteria and bacterial EV in small intestinal fluids is displayed at the phylum (C), genus (D), and species (E) levels. As for genus and species, the proportion less than 1% occupancy is noted as others.CC BY · PubMed Central
Figure 4 Change of stool bacteria and bacterial EV following 3% DSS administration. For all figures, stool bacteria and EV were isolated from mice before (D0) and 5 days (D5) after 3% DSS oral administration (each group = 5). As for EV metagenomics, two independent experiments were performed. (A) Phylogenetic trees of stool bacteria and bacterial EV. (B) Principal component analysis (PCA) of bacterial EV (left panel) and changes of candidate bacteria and bacterial EV following 3% DSS administration (right panel). Blue circle means 95% confidence interval, and green cross means the starting point to diverge each species.
Figure 4 Change of stool bacteria and bacterial EV following 3% DSS administration. For all figures, stool bacteria and EV were isolated from mice before (D0) and 5 days (D5) after 3% DSS oral administration (each group = 5). As for EV metagenomics, two independent experiments were performed. (A) Phylogenetic trees of stool bacteria and bacterial EV. (B) Principal component analysis (PCA) of bacterial EV (left panel) and changes of candidate bacteria and bacterial EV following 3% DSS administration (right panel). Blue circle means 95% confidence interval, and green cross means the starting point to diverge each species.CC BY · PubMed Central
Figure 5 Characterization and immunogenicity of A. muciniphila-derived EV. (A) A TEM image (×100 k) showing a spherical shape of A. muciniphila EV. (B) Size (d.nm) of A. muciniphila EV measured by NTA. (C) Levels of a pro-inflammatory cytokine IL-6. IL-6 was measured 12 h after A. muciniphila-derived EV treated to peritoneal macrophage cell line (Raw264.7, left panel) and colon epithelial cell line (CT26, right panel). LPS: lipopolysaccharide, 75 ng/ml, Ec EV: E. coli-derived EV, 100 ng/ml; Am EV: A. muciniphila–derived EV. (D) In vitro anti-inflammatory effect of A. muciniphila EV. IL-6 levels were measured in supernatants of colon epithelial cells (CT26) after A. muciniphila EV were pre-treated to CT26 for 12 h and then 100 ng/ml of E. coli EV treated for 12 h. **, p<0.01 by ANOVA and test of linearity.
Figure 5 Characterization and immunogenicity of A. muciniphila-derived EV. (A) A TEM image (×100 k) showing a spherical shape of A. muciniphila EV. (B) Size (d.nm) of A. muciniphila EV measured by NTA. (C) Levels of a pro-inflammatory cytokine IL-6. IL-6 was measured 12 h after A. muciniphila-derived EV treated to peritoneal macrophage cell line (Raw264.7, left panel) and colon epithelial cell line (CT26, right panel). LPS: lipopolysaccharide, 75 ng/ml, Ec EV: E. coli-derived EV, 100 ng/ml; Am EV: A. muciniphila–derived EV. (D) In vitro anti-inflammatory effect of A. muciniphila EV. IL-6 levels were measured in supernatants of colon epithelial cells (CT26) after A. muciniphila EV were pre-treated to CT26 for 12 h and then 100 ng/ml of E. coli EV treated for 12 h. **, p<0.01 by ANOVA and test of linearity.CC BY · PubMed Central
Figure 6 In vivo protective effect of A. muciniphila-derived EV on the development of 2% DSS-induced colitis. For all figures, mice (each group = 5) were ingested by A. muciniphila (Bacteria, 5.0×108) or A. muciniphila-derived EV (Am EV, 100 µg), concomitantly with water or 2% DSS. (A) Body weight changes (%). (B) Colon lengths. **, p<0.01. (C) Changes of disease activity index, reflected by body weight, colon length, diarrhea, and stool blood. (D) Histology (upper panel) and histological activity index (lower panel) of colon. Arrows indicate injury area, and histological activity index was measured by epithelial barrier disruption and infiltration depth of inflammatory cells. *. p<0.05 vs. the DSS and DSS+Bacteria groups.
Figure 6 In vivo protective effect of A. muciniphila-derived EV on the development of 2% DSS-induced colitis. For all figures, mice (each group = 5) were ingested by A. muciniphila (Bacteria, 5.0×108) or A. muciniphila-derived EV (Am EV, 100 µg), concomitantly with water or 2% DSS. (A) Body weight changes (%). (B) Colon lengths. **, p<0.01. (C) Changes of disease activity index, reflected by body weight, colon length, diarrhea, and stool blood. (D) Histology (upper panel) and histological activity index (lower panel) of colon. Arrows indicate injury area, and histological activity index was measured by epithelial barrier disruption and infiltration depth of inflammatory cells. *. p<0.05 vs. the DSS and DSS+Bacteria groups.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

Items 501–542 of 542

Metadata

Authors
Kang, C.-S., Ban, M., Choi, E.-J., Moon, H.-G., Jeon, J.-S., Kim, D.-K., Park, S.-K., Jeon, S. G., Roh, T.-Y., Myung, S.-J., Gho, Y. S., Kim, J. G., & Kim, Y.-K.
Affiliations
  • Pohang University of Science and Technology (KR)
  • Asan Medical Center (KR)
  • Chung-Ang University Healthcare System (KR)
Corresponding author
  • Gho, Yong Song
  • Kim, Jae Gyu
  • Kim, Yoon-Keun
Venue
PLoS ONE
Published
2013-10-24
Volume
8
Issue
10
Pages
e76520
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2086465908
Cited by
543
References
36
Citations by year
2026: 33 · 2025: 53 · 2024: 55 · 2023: 67 · 2022: 58 · 2021: 73 · 2020: 58 · 2019: 34 · 2018: 39 · 2017: 30 · 2016: 23 · 2015: 10 · 2014: 10
FWCI
6.42
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Open Access System for Information Sharing (Pohang University of Science and Technology) (submittedVersion)
Funders
  • National Research Foundation
  • Pohang University of Science and Technology
  • Korea Research Institute of Bioscience and Biotechnology
  • National Research Foundation of Korea (2011-0000879)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords
extracellular vesicles, gut microbiota, Akkermansia muciniphila, DSS-induced colitis, inflammatory bowel disease, intestinal inflammation, Bacteroides acidifaciens, interleukin-6, Escherichia coli, intestinal immunity, intestinal homeostasis, commensal bacteria
MeSH terms
Animals, Colitis, Disease Models, Animal, Female, Inflammatory Bowel Diseases, Dextran Sulfate, Disease Progression, Secretory Vesicles, Mice, Metagenome, Bacterial Secretion Systems, Verrucomicrobia, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.